Showing results (11-20 of 437) with videos related to
Sort By:
Pageof 44
Rheumatology (Oxford, England)|January 10, 2014
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targetsDaniel E Furst, Paul EmeryExpert Opinion on Drug Safety|June 5, 2020
Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritisRoy Fleischmann, Daniel E FurstEuropean Journal of Rheumatology|November 9, 2020
The burning question: To use or not to use cyclophosphamide in systemic sclerosisCosimo Bruni, Daniel E FurstArthritis Research & Therapy|June 6, 2019
Targeting inflammatory pathways in axial spondyloarthritisDaniel E Furst, James S LouieClinics in Geriatric Medicine|May 25, 2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E FurstArthritis Research & Therapy|August 29, 2014
Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacyThasia G Woodworth, Daniel E FurstRheumatic Diseases Clinics of North America|July 27, 2015
Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic ApproachesElizabeth R Volkmann, Daniel E FurstExpert Review of Clinical Immunology|July 11, 2017
Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic reviewAly M Aly, Daniel E FurstCurrent Opinion in Rheumatology|November 1, 2002
Stem cell therapy in sclerodermaYolanda Braun-Moscovici, Daniel E FurstCurrent Opinion in Rheumatology|April 23, 2003
Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E FurstPageof 44